Shanghai Shen Lian Biomedical Corp
SSE:688098

Watchlist Manager
Shanghai Shen Lian Biomedical Corp Logo
Shanghai Shen Lian Biomedical Corp
SSE:688098
Watchlist
Price: 9.67 CNY 1.9% Market Closed
Market Cap: 4B CNY

Wall Street
Price Targets

Price Targets Summary
Shanghai Shen Lian Biomedical Corp

There are no price targets for Shanghai Shen Lian Biomedical Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shanghai Shen Lian Biomedical Corp Competitors:
Price Targets
INVA
Innoviva Inc
69% Upside
KOTRA
Kotra Industries Bhd
93% Downside
300723
Yipinhong Pharmaceutical Co Ltd
22% Upside
CONCORDBIO
Concord Biotech Ltd
29% Upside
NEULANDLAB
Neuland Laboratories Ltd
47% Upside
LPCN
Lipocine Inc
12% Downside
PFE
Pfizer Inc
15% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Shen Lian Biomedical Corp

For the last 7 years the compound annual growth rate for Shanghai Shen Lian Biomedical Corp's revenue is 0%. The projected CAGR for the next 1 year is 119%.

0%
Past Growth
119%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai Shen Lian Biomedical Corp

Operating Income forecast
is not available for
Shanghai Shen Lian Biomedical Corp

Net Income
Forecast

Net Income Estimate
Shanghai Shen Lian Biomedical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Shen Lian Biomedical Corp's stock price target?
Not Available

Shanghai Shen Lian Biomedical Corp doesn't have any price targets made by Wall Street professionals.

What is Shanghai Shen Lian Biomedical Corp's Revenue forecast?
Projected CAGR
119%

For the last 7 years the compound annual growth rate for Shanghai Shen Lian Biomedical Corp's revenue is 0%. The projected CAGR for the next 1 year is 119%.

Back to Top